Disseminated encephalomyelitis in adults

Clinical Neurology and Neurosurgery

Volumn 110, Issue 9, 2008, Pages 913-918

  Brinar, Vesna V ^a   Poser, Charles M ^a  

^a Ministry of Health   (Croatia)

Author keywords

Acute disseminating encephalomyelitis recurrent; Disseminating encephalomyelis; Multiphasic DEM; NMO

Indexed keywords

ACICLOVIR; AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; CARBAMAZEPINE; STEROID; UNCLASSIFIED DRUG;

ASTROCYTE; DEMYELINATING DISEASE; DISSEMINATED ENCEPHALOMYELITIS; GRAND MAL SEIZURE; HUMAN; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; REVIEW; SYMPTOMATOLOGY;

ADULT; ANTI-INFLAMMATORY AGENTS; CENTRAL NERVOUS SYSTEM INFECTIONS; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; EPILEPSY, TONIC-CLONIC; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEPATITIS B VACCINES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROMYELITIS OPTICA; PNEUMONIA, MYCOPLASMA; STEROIDS; VACCINATION; YOUNG ADULT;

EID: 53549131240     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.06.015     Document Type: Review

References (39)

1. Trojano M., and Paollicelli D. The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes. Neurol Sci 22 Suppl. 2 (2001) S98-S102
2. Goodin D. The use of MRI in the diagnosis of multiple sclerosis. Lancet Neurol l5 (2006) 808-809
3. Hartung H.P., and Grossman R. ADEM: distinct disease or part of MS spectrum?. Neurology 56 (2001) 1257-1260
4. Weinschenker B., and Miller D. Multiple sclerosis: one disease or many. In: Siva A., Kesselring J., and Thompson A. (Eds). Frontiers in multiple sclerosis (1999), Martin Dunitz, London 37-46
5. Scolding N. The differential diagnosis of multiple sclerosis. Neurol Neurosurg Psychiatry 71 Suppl. 1 (2001) 119-215
6. Poser C.M. Revisions to the 2001 McDonald diagnostic criteria. Ann Neurol 59 (2006) 727-728
7. Seewann A., Enzinger C., Filippi M., et al. MAGNIMS network. MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: a review of reported findings. J Neurol 255 (2008) 1-10
8. Poser C.M., and Brinar V.V. Disseminated encephalomyelitis and multiple sclerosis: two different diseases-a critical review. Acta Neurol Scand 116 (2007) 201-206
9. Brinar V.V., and Poser C.M. The spectrum of disseminated encephalomyelitis. Clin Neurol Neurosurg 108 (2006) 295-310
10. Brinar V.V. Non MS recurrent demyelinating disease. Clin Neurol Neurosurg 106 (2004) 197-210
11. Wingerchuk D.M. The clinical course of acute disseminated encephalomyelitis. Neurol Res 28 (2006) 341-347
12. Poser C.M. Multiple sclerosis and recurrent disseminated encephalomyelitis are different diseases. Arch Neurol 65 (2008) 674-675
13. de Sèze J., Debouverie M., Zephir H., et al. Acute fulminant demyelinating disease. Arch Neurol 64 (2007) 1426-1432
14. Poser C. Disseminated vasculomyelinopathy. Acta Neurol Scand 45 Suppl. 37 (1969) 1-44
15. Miller H., Stanton J., and Gibbons J. Parainfectious encephalomyelitis and related syndromes. Quart J Med (NS) 25 (1956) 427-505
16. Croft P. Parainfectious and postvaccinal encephalomyelitis. Postgrad Med J 45 (1969) 392-400
17. DeVries E. Postvaccinal perivenous encephalomyelitis and related syndromes (1960), Elsevier, Amsterdam
18. Tourbah A., Gout O., Liblau R., et al. Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS?. Neurology 53 (1999) 396-401
19. Touzé E., Fourrier A., Rue-Fenouche C., et al. Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study. Neuroepidemiology 21 (2002) 180-186
20. Poser C.M. The environment and the nervous system. J Neurol Sci 262 (2007) 98-99
21. Poser C.M. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect. Clin Neurol Neurosurg 108 (2006) 227-233
22. Poser CM. Unpublished data, personal communication.
23. Poser C.M. The epidemiology of multiple sclerosis. A general overview. Ann Neurol 36 Suppl. 2 (1994) S180-S193
24. Unal I., Dogulu F., Saygi S., et al. Multiphasic disseminated encephalomyelitis: a 4 year follow up. Eur Neurol 43 (2000) 55-58
25. Wingerchuk D.M., Lennon V.A., Pittock S.J., et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489
26. Pittock S.J., Weinshenker B.G., Lucchinetti C.F., et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin-4 expression. Arch Neurol 63 (2006) 964-968
27. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., et al. The spectrum of neuromyelitis optica. Lancet Neurol 6 (2007) 805-815
28. Wingerchuk D.M., and Weinshenker B.G. Neuromyelitis optica. Curr Treat Options Neurol 10 (2008) 55-66
29. Weinshenker B.G., and Wingerchuk D.M. Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker. Curr Top Microbiol Immunol 318 (2008) 343-356
30. Leite I. Personal communications, unpublished data.
31. Brinar M., Radoš M., Habek M., and Poser C.M. Enlargement of the spinal cord: inflammation or neoplasm. Clin Neurol Neurosurg 108 3 (2006) 284-290
32. Jacob A., and Weinshenker B.G. An approach to the diagnosis of acute transverse myelitis. Semin Neurol 28 (2008) 105-120
33. Young N.P., Weinshenker B.G., and Lucchinetti C.F. Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol 28 (2008) 84-94
34. Nolte C.H., Endres A.S., and Meisel H. Sensory ataxia in myelopathy with chronic hepatitis C virus infection. Neurology 59 (2002) 958-959
35. Zandman-Goddard G., Levy Y., Weiss P., et al. Transverse myelitis associated with chronic hepatitis C. Clin Exp Rheumatol 21 (2003) 111-113
36. Annunziata P., Marroni M., Francisci D., et al. Acute transverse myelitis and hepatitis C virus. Infez Med 13 (2005) 45-47
37. Poser C.M., Roman G., and Emery III E. Recurrent acute necrotizing encephalopathy. Arch Neurol 35 (1978) 166-170
38. Reik L. Disseminated vasculomyelinopathy: an immune complex disease. Ann Neurol 7 (1980) 291-296
39. Cabre P., Smadja D., Merle H., et al. Multiphasic disseminated encephalomyelitis, after electric injury. Neurol Infect Epidemiol 2 (1997) 135-139